Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Sponsor: Akiva Mintz
Summary
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer that binds to a tumor specific protein called somatostatin receptor 2 (SSTR2) and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Official title: Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake
Key Details
Gender
All
Age Range
18 Years - 120 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-12-11
Completion Date
2030-04-30
Last Updated
2026-04-08
Healthy Volunteers
Yes
Interventions
68Ga-Dotatate
Participants will be injected with 68Ga-DOTATATE and imaged for up to 3 hours on a PET scanner
Locations (1)
Nuclear Imaging Institute
Englewood, New Jersey, United States